We Are Known For Our

CREDIBILITYVERSATILITYEXPERTISECAPABILITYINTEGRITYRESPECTTRUSTRELATIONSHIPSCOLLABORATIONREPUTATIONINSIGHTSKNOWLEDGEHONESTY
SERVICES
GET IN TOUCH

  • Arvind Mani

    Managing Director
    Arvind Mani
    Managing Director

  • Sherry O'Quinn

    Managing Principal
    Sherry O’Quinn
    Managing Principal

  • Jaclyn Beca

    Director of Pharmacoeconomics and RWE
    Jaclyn Beca
    Director of Pharmacoeconomics and RWE

  • Sang Mi Lee

    Director of Innovative Access Solutions
    Sang Mi Lee
    Director of Innovative Access Solutions

  • Anita Carrie

    Principal, Health Technology Assessment (HTA)
    Anita Carrie
    Principal, Health Technology Assessment (HTA)

  • Katherine Scott

    Senior Consultant
    Katherine Scott
    Senior Consultant

MORSE Services

icon1

STRATEGIC ADVICE

MORSE Consulting offers ongoing strategic advice to optimize the prospect of reimbursement success throughout the Canadian pharmaceutical lifecycle.
icon2

ANALYSES

MORSE Consulting develops tailored reimbursement assessments and analyses to meet a client’s evolving needs – from comprehensive reimbursement landscape assessments to detailed time-to-listing analyses.
icon3

ADVISORY BOARDS

MORSE Consulting organizes, facilitates, and participates in numerous types of advisory boards. This includes negotiation simulation sessions which help clients gauge payer reaction to a range of proposals.
icon4

TRAINING

MORSE Consulting delivers training sessions on the Canadian pharmaceutical reimbursement environment that can be customized for various target audiences.

MORSE Values

Excellence

EXCELLENCE

We prioritize our team’s welfare and the quality of services and products we deliver to our clients while constantly looking for ways to improve.
Integrity

INTEGRITY

We choose actions that reflect honesty and fairness; we honour our commitments and acknowledge our mistakes.
Respect

RESPECT

We communicate with openness, authenticity, kindness and respect and value the time, capability and intentions of everyone we work with.
Collaboration

COLLABORATION

We achieve success by building meaningful relationships and openly collaborating in the pursuit of excellence.

EXCELLENCE

We prioritize our team’s welfare and the quality of services and products we deliver to our clients while constantly looking for ways to improve.

INTEGRITY

We choose actions that reflect honesty and fairness: we honour our commitments and acknowledge our mistakes.

RESPECT

We communicate with openness, authenticity, kindness and respect and value the time, capability and intentions of everyone we work with.

COLLABORATION

We achieve success by building meaningful relationships and openly collaborating in the pursuit of excellence.

MORSE Reports

NEW Canadian Reimbursement Trends and Timelines Report Released!

Industry Feedback...

“The market access timelines within Canada are a broad and important issue and therefore, there is significant value in providing this information to companies on a regular basis. Global head offices frequently have questions regarding the Canadian reimbursement processes particularly after HTA recommendation. This slide deck would be a valuable tool for market access groups and business units to answer these questions and set internal expectations.”

– General Manager
Ontario-based Pharmaceutical Company

 “In our world of market access we know the processes inside and out, but where the advantage of this MORSE report lies for individuals like myself is in painting the picture of the public reimbursement process and timelines with our internal commercial teams, senior management and global voices as we determine launch plans for products in Canada.”

– Public Affairs Lead
Ontario-based Pharmaceutical Company

“This report is a useful tool to sensitize stakeholders, in particular MORSE’s expertise will allow us to answer internal questions regarding pCPA negotiations and timing of the letter of intent.” 

– Market Access Director
Quebec-based Pharmaceutical Company

“When working with stakeholders, such as patient groups, the timeline content of the report would be useful in order to map out strategy and timing. Ultimately, it would facilitate coordination across many silos, including internally within the Canadian team, the global team and with external stakeholders such as patient groups and payers.”

– Director of Market Access & Government Affairs
Ontario-based Pharmaceutical Company
Learn More

MORSE Signals

Timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

Career Opportunity at MORSE for Senior Consultant (HTA)

March 9, 2023
-
Careers, What's New
We are seeking an individual with similar values, a passion for learning and an interest in making a meaningful contribution to consulting projects and our overall...
Read More →
Posted by MORSE
4 MIN READ

MORSE Consulting Releases its pCPA Quarterly Update – Q4 2022

February 9, 2023
-
Market Access News, Publications
For a more in-depth look at market access trends and timelines comparing 2021 data to that of the past four years, order MORSE Consulting’s Canadian Reimbursement and Forecasting…
Read More →
Posted by MORSE
1 MIN READ

Season’s Greetings from MORSE Consulting 2022

December 13, 2022
-
Market Access News, What's New
Happy Holidays from MORSE Consulting! As we enter the festive season and close our sixth year of operations, we express our heartfelt gratitude to the pharmaceutical market access…
Read More →
Posted by MORSE
1 MIN READ

MORSE Key

Pharmaceutical Market Access Events Calendar

No event found!

MORSE Careers

We are always looking for bright, passionate, and motivated individuals, so check out our open positions or send us your resumé.

Career Opportunity at MORSE for Senior Consultant (HTA)

March 9, 2023
-
Careers, What's New
We are seeking an individual with similar values, a passion for learning and an interest in making a meaningful contribution to consulting projects and our overall...
Read More →
Posted by MORSE
4 MIN READ
MORSE Consulting Inc. - Deciphering Pharmaceutical Market Access